CIK 0001598646
- Non-accelerated filer
- Smaller reporting company
Minerva Neurosciences, Inc.
Sign in to watch- Ticker
- NERV
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- MA
- Entity type
- Operating
- EIN
- 260784194
- Phone
- +1 617-600-7373
- Business address
- 1500 DISTRICT AVENUE, BURLINGTON, MA, 01803
- 4 Derivatives Options or other derivatives
- 4 Open-market sale 10% owner sold 22,918 shares at an average $6.02 ($137,896)
- 4 Open-market sale 10% owner sold 134,828 shares at an average $6.66 ($898,161)
- 4 Open-market buy Director bought 2,000 shares at $6.50 ($13,000)
- 4 Open-market sale EVP, CFO & CBO sold 5,999 shares at $7.46 ($44,753)
- 4 Open-market sale SVP, Chief Accounting Officer sold 1,559 shares at $7.46 ($11,630)
- 4 Open-market sale CEO sold 2,604 shares at $7.46 ($19,426)
- 4 Open-market sale SVP & Chief Operating Officer sold 2,728 shares at $7.46 ($20,351)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market sale President sold 3,117 shares at $7.96 ($24,811)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market buy Director bought 6,000 shares at an average $7.97 ($47,800)
- 4 Open-market buy Director bought 2,000 shares at $8.20 ($16,400)
- 4 Open-market buy Director bought 600 shares at $10.00 ($6,000)
- 4 Open-market sale SVP & Chief Operating Officer sold 25,000 shares at an average $12.06 ($301,520)
Page 7 of 14 · 264 filings